Financial reports
10-K
2023 FY
Annual report
1 Apr 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
17 May 23
NT 10-Q
Notice of late quarterly filing
16 May 23
10-K
2022 FY
Annual report
31 Mar 23
10-Q
2022 Q3
Quarterly report
21 Nov 22
NT 10-Q
Notice of late quarterly filing
15 Nov 22
10-Q
2022 Q2
Quarterly report
17 Aug 22
NT 10-Q
Notice of late quarterly filing
15 Aug 22
Current reports
8-K
WEED Inc. (USA) Acquires Hempirical Genetics LLC, w/Over 250 Proprietary Cannabis & Hemp Strains for $750,000.00
4 Aug 22
8-K
Entry into a Material Definitive Agreement
10 Dec 21
8-K
Entry into a Material Definitive Agreement
8 Mar 21
8-K
WEED, Inc. Takes Important First Step
10 Jul 19
8-K
WEED, Inc. Signs First-of-its-Kind Agreement on Key Cannabis-Related Intellectual Property in Israel
7 Mar 19
8-K
Departure of Directors or Certain Officers
20 Sep 18
8-K
Other Events
16 Sep 14
8-K
Other Events
10 Apr 13
8-K
Other Events
10 Jan 13
8-K
Other Events
2 Nov 12
Registration and prospectus
253G2
Offering circular supplement
9 Mar 21
253G2
Offering circular supplement
28 Jan 21
1-A/A
Offering $40M in Equity
14 Dec 20
1-A/A
Offering $40M in Equity
14 Oct 20
1-A/A
Offering $40M in Equity
15 Jul 20
1-A
Offering $40M in Equity
12 Feb 20
424B3
Prospectus supplement
26 Aug 19
424B3
Prospectus supplement
30 Jul 19
424B3
Prospectus supplement
21 May 19
424B3
Prospectus supplement
16 May 19
Other
QUALIF
Notice of qualification
15 Jan 21
CORRESP
Correspondence with SEC
12 Jan 21
UPLOAD
Letter from SEC
2 Nov 20
UPLOAD
Letter from SEC
6 Aug 20
UPLOAD
Letter from SEC
10 Mar 20
EFFECT
Notice of effectiveness
9 Aug 18
CORRESP
Correspondence with SEC
6 Aug 18
UPLOAD
Letter from SEC
25 May 18
UPLOAD
Letter from SEC
11 May 18
UPLOAD
Letter from SEC
20 Feb 18